Kakonein/Fructose

葛根素/果糖

Report date: 2023/03/05 16:38:19

Base Information

Drug NameKakonein/Fructose
Drug Alias Name葛根素葡萄糖注射液由若普润
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated L-type calcium channel blockersCalcium-activated potassium channel alpha/beta 1 agonistsCarbohydrate supplements
TargetsCalcium-activated potassium channel alpha/beta 1Voltage-gated L-type calcium channel
Therapy Area/IndicationsMyocardial InfarctionCoronary DiseaseAngina Pectoris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes KakoneinFructose
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsMyocardial InfarctionCoronary DiseaseAngina Pectoris
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A